Advertisement
Australia markets open in 9 hours 15 minutes
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • AUD/USD

    0.6486
    +0.0035 (+0.54%)
     
  • ASX 200

    7,683.50
    +34.30 (+0.45%)
     
  • OIL

    82.08
    +0.18 (+0.22%)
     
  • GOLD

    2,333.50
    -12.90 (-0.55%)
     
  • Bitcoin AUD

    102,938.67
    +701.62 (+0.69%)
     
  • CMC Crypto 200

    1,437.84
    +23.08 (+1.63%)
     

Top Ranked Momentum Stocks to Buy for October 9th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 9th:

Frontline Ltd. (FRO): This shipping company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 34.2% over the last 60 days.

Frontline Ltd. Price and Consensus

Frontline Ltd. Price and Consensus
Frontline Ltd. Price and Consensus

Frontline Ltd. price-consensus-chart | Frontline Ltd. Quote

Frontline’s shares gained 25% over the last one month more than S&P 500’s decline of 2.9%. The company possesses a Momentum Score of B.

Frontline Ltd. Price

Frontline Ltd. Price
Frontline Ltd. Price

Frontline Ltd. price | Frontline Ltd. Quote

ADVERTISEMENT

Cesca Therapeutics Inc. (KOOL): This developer of cell-based therapeutics has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 86% over the last 60 days.

Cesca Therapeutics Inc. Price and Consensus

Cesca Therapeutics Inc. Price and Consensus
Cesca Therapeutics Inc. Price and Consensus

Cesca Therapeutics Inc. price-consensus-chart | Cesca Therapeutics Inc. Quote

Cesca Therapeutics’ shares gained 49.5% over the last one month. The company possesses a Momentum Score of A.

Cesca Therapeutics Inc. Price

Cesca Therapeutics Inc. Price
Cesca Therapeutics Inc. Price

Cesca Therapeutics Inc. price | Cesca Therapeutics Inc. Quote

Cortexyme, Inc. (CRTX): This pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.2% over the last 60 days.

Cortexyme, Inc. Price and Consensus

Cortexyme, Inc. Price and Consensus
Cortexyme, Inc. Price and Consensus

Cortexyme, Inc. price-consensus-chart | Cortexyme, Inc. Quote

Cortexyme’s shares gained 10.8% over the last one month. The company possesses a Momentum Score of A.

Cortexyme, Inc. Price

Cortexyme, Inc. Price
Cortexyme, Inc. Price

Cortexyme, Inc. price | Cortexyme, Inc. Quote

Coeur Mining, Inc. (CDE): This mining company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.7% over the last 60 days.

Coeur Mining, Inc. Price and Consensus

Coeur Mining, Inc. Price and Consensus
Coeur Mining, Inc. Price and Consensus

Coeur Mining, Inc. price-consensus-chart | Coeur Mining, Inc. Quote

Coeur Mining’s shares gained 12.6% over the last one month. The company possesses a Momentum Score of B.

Coeur Mining, Inc. Price

Coeur Mining, Inc. Price
Coeur Mining, Inc. Price

Coeur Mining, Inc. price | Coeur Mining, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cesca Therapeutics Inc. (KOOL) : Free Stock Analysis Report
 
Frontline Ltd. (FRO) : Free Stock Analysis Report
 
Cortexyme, Inc. (CRTX) : Free Stock Analysis Report
 
Coeur Mining, Inc. (CDE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research